Biomerica (BMRA) Receivables - Other (2019 - 2026)

Biomerica (BMRA) has 8 years of Receivables - Other data on file, last reported at $978000.0 in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 24.36% year-over-year to $978000.0; the trailing twelve-month figure through Feb 2026 stood at $978000.0 (down 24.36% YoY), and the FY2025 full-year result was $757000.0, down 21.64% from the prior year.
• Receivables - Other declined to $978000.0 in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $1.6 million in Q3 2024 to a low of $751000.0 in Q2 2023.
• A 5-year average of $1.1 million and a median of $1.1 million in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other plunged 59.55% in 2022 and rose 28.63% in 2024, its largest moves.
• Tracing BMRA's Receivables - Other over 5 years: stood at $927000.0 in 2022, then increased by 17.48% to $1.1 million in 2023, then rose by 24.24% to $1.4 million in 2024, then decreased by 22.91% to $1.0 million in 2025, then dropped by 6.23% to $978000.0 in 2026.
• Business Quant data shows BMRA's Receivables - Other at $978000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.3 million in Q3 2025.